Assessment of clinical enzyme methodology: A probabilistic approach

Clinica Chimica Acta

Volumn 257, Issue 1, 1997, Pages 25-40

  Henderson, A Ralph ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Bayes' Theorem; Decision threshold; ROC curve

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB;

BLOOD ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; ENZYME ASSAY; EXPERT SYSTEM; HEART INFARCTION; HUMAN; HUMAN TISSUE; INFORMATION PROCESSING; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REGRESSION ANALYSIS; TECHNIQUE;

ENZYME TESTS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; PREDICTIVE VALUE OF TESTS; PROBABILITY;

EID: 0031014864     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(96)06432-7     Document Type: Conference Paper

References (44)

1. Kazmierczak SC, Catrou PG. Clinical informatics. Anal Chem 1995;67:437R-441R.
2. Armitage P, Berry G. Statistical methods in medical research. 3rd edn. Oxford: Blackwell, 1994;402-447 and 312-385.
3. Grimson JB. Integrating knowledge-based systems and databases. Clin Chim Acta 1993;222:101-115.
4. Hecht-Nielsen R. Neurocomputing. Reading, MA: Addison-Wesley, 1990;1-433.
5. Baxt WG. Use of an artificial neural network for the diagnosis of myocardial infarction. Ann Intern Med 1991;115:843-848.
6. Furlong JW, Dupay ME, Heinsimer JA. Neural network analysis of serial cardiac enzyme data. A clinical application of artificial machine intelligence. Am J Clin Pathol 1991;96:134-141.
7. Snow PB, Smith DS, Catalona WJ. Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J Urol 1994;152:1923-1926.
8. Cross SS, Harrison RF, Kennedy RL. Introduction to neural networks. Lancet 1995;346:1075-1079.
9. Baxt WG. Application of artificial neural networks to clinical medicine. Lancet 1995;346:1135-1138.
10. Dybowski R, Gant V. Artificial neural networks in pathology and medical laboratories. Lancet 1995;346:1203-1207.
11. Wyatt J. Nervous about artificial neural networks [Commentary]. Lancet 1995;346:1175-1177.
12. Feinstein AR. Clinical epidemiology: the architecture of clinical research. Philadelphia, PA: Saunders, 1985;609.
13. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine [Review]. Clin Chem 1993;39:561-577.
14. Henderson AR. Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis [Review]. Ann Clin Biochem 1993;30:521-539.
15. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. New Engl J Med 1978;299:926-930.
16. Kassirer JP, Kopelman RI. Learning clinical reasoning. Baltimore: Williams and Wilkins, 1991;23.
17. Rowley JM, Hamptom JR. Diagnostic criteria for myocardial infarction. Br J Hosp Med 1981;26:253-258.
18. Roberts R. The two out of three criteria for the diagnosis of infarction: Is it passe? Chest 1984;86:511-513.
19. Siegel AJ, Lewandrowski KB, Strauss HW, Fischman AJ, Yasuda T. Normal post-race antimyosin myocardial scintigraphy in asymptomatic marathon runners with elevated serum creatine kinase MB isoenzyme and troponin T levels. Cardiology 1995;86:451-456.
20. Hafner G, Thome-Kromer B, Schaube J et al. Cardiac troponins in serum in chronic renal failure [Letter]. Clin Chem 1994;40:1790-1791.
21. Bhayana V, Gougoulias T, Cohoe S, Henderson AR. Discordance between results for serum troponin T and troponin I in renal disease [Case Report]. Clin Chem 1995;41:312-317.
22. Li D, Keffer J, Corry K, Vazquez M, Jialal I. Nonspecific elevation of troponin T levels in patients with chronic renal failure. Clin Biochem 1995;28:474-477.
23. Katus HA, Haller C, Müller-Bardorff M, Scheffold T, Remppis A. Cardiac troponin T in end-stage renal disease patients undergoing chronic maintenance hemodialysis [Letter]. Clin Chem 1995;41:1201-1202.
24. Hafner G, Thome-Kromer B, Schaube J et al. Response to Letter of Katus et al. [Letter]. Clin Chem 1995;41:1202-1203.
25. Croitoru M, Taegtmeyer H. Spurious rises in troponin T in end-stage renal disease [Letter]. Lancet 1995;346:974.
26. Bertsch T, Resch S. Differentialdiagnotische bedeutung von troponin T im serum: myokardinfarkt, rhabdomyolyse oder niereninsuffizienz? Dtsch Med Wochenschr 1995;120:1392-1394.
27. Reid MC, Lachs MS, Feinstein AR. Use of methodological standards in diagnostic test research. Getting better but still not good enough. J Am Med Assoc 1995;274:645-651.
28. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
29. Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Mak 1993;13:313-321.
30. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993;12:1293-1316.
31. Wu AHB, Lane PL. Metaanalysis in clinical chemistry: validation of cardiac troponin T as a marker of ischemic heart disease. Clin Chem 1995;41:1228-1233.
32. Shultz EK. Multivariate receiver-operating characteristic curve analysis: prostate cancer screening as an example. Clin Chem 1995;41:1248-1255.
33. Henderson AR, Bhayana V. A modest proposal for the consistent presentation of ROC plots in Clinical Chemistry [Letter]. Clin Chem 1995;41:1205-1206.
34. van Steirteghem AC, Zweig MH, Robertson EA, Bernard RM, Putzeys GA, Bieva CJ. Comparison of the effectiveness of four clinical chemical assays in classifying patients with chest pain. Clin Chem 1982;28:1319-1324.
35. Werner M, Brooks SH, Mohrbacher RJ, Wasserman AG. Diagnostic performance of enzymes in the discrimination of myocardial infarction. Clin Chem 1982;28:1297-1302.
36. Leung FY, Galbraith LV, Jablonsky G, Henderson AR. Re-evaluation of the diagnostic utility of serum total creatine kinase and creatine kinase-2 in myocardial infarction. Clin Chem 1989;35:1435-1440.
37. Feinstein AR. Clinical biostatistics. St Louis: CV Mosby, 1977;1-468.
38. Fagan TJ. A nomogram for applying likelihood ratios. New Engl J Med 1975;293:257.
39. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology. A basic science for clinical medicine. 2nd edn. Boston: Little, Brown and Company, 1991;1-441.
40. Albert A. On the use and computation of likelihood ratios in clinical chemistry. Clin Chem 1982;28:1113-1119.
41. Jaeschke R, Guyatt GH, Sackett DL, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? J Am Med Assoc 1994;271:703-707.
42. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843.
43. Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986;110:13-20.
44. National Committee for Clinical Laboratory Standards. Assessment of the clinical accuracy of laboratory tests using receiver operating characteristic (ROC) plots; tentative guideline. NCCLS Document GP-10T (ISBN 1-56238-213-6). NCCLS Doc 1993;13(28):1-41.